health news arrowHome >> Children's Health >> 2.5 Million Children Taking Drugs for ADHD Mon, 23 Nov 2009 GMT 
health news
  NEWS YOU CAN TRUST

Search Health News 
Browser Preferences
 Add to Favorites

Main Menu
 Home
 - - - - - Hot Topics - - - - -
 Bird Flu
 Drug Safety
 Stem Cell Research
 - - - - - - - - - - - - - - - - -
 Alternative Medicine
 Children's Health
 Diet & Nutrition
 Disabilities
 *Diseases & Conditions
 Drugs & Herbs
 Environmental Health
 Fitness & Exercise
 Genetic Research
 Health Insurance
 Medical Ethics
 Men's Health
 *Mental Illness
 Pain
 Parenting
 Public Health & Safety
 Senior Care
 *Sexual Health
 Women's Health
 World Health
 - - - - - - - - - - - - - - - -
 Web Links
 Contact Us: info@dailynewscentral.com

XML News Feeds


 

HEALTH NEWS

2.5 Million Children Taking Drugs for ADHD

PDF  Print  E-mail
 02 September, 2005  16:40 GMT

ADHD US children medication
The prevalence of ADHD diagnosis was higher among non-Hispanic, English-speaking, insured children, and even higher for children in families in which adults had more education.
As many children in the United States are now being medicated for attention-deficit hyperactivity disorder (ADHD) as are being medicated for asthma. And many more children aged 4 to 17 have received a diagnosis for the disorder, according to a new US Centers for Disease Control and Prevention report.

"This is the first report that has enumerated the number of children who have ever had an ADHD diagnosis and are currently medicated," said Suzanne Visser, an epidemiologist with the CDC's National Center on Birth Defects and Developmental Disabilities. "We know for the first time that approximately 2.5 million children are being medicated for ADHD. That is a new number, and it is a large number."

Visser was first author of the report, which appears in this week's issue of Morbidity and Mortality Weekly, a publication of the CDC.

Inability to Pay Attention, Hyperactivity, Impulsivity

The data enables experts to make comparisons with other diseases, as well as to more correctly pinpoint the burden of ADHD, Visser added.

ADHD is a neurobehavioral disorder characterized by the inability to pay attention, hyperactivity and impulsivity. Stimulants are the first-line treatment for the disorder, but there has been much concern about the safety of this approach including, recently, debates at the US Food and Drug Administration as to whether to make labeling changes for a class of ADHD drugs that includes Ritalin.

To estimate rates of parent-reported diagnosis and treatment of ADHD, the authors of this report analyzed data from the 2003 National Survey of Children's Health. Interviewers had asked parents of children aged 4 to 17 whether a healthcare provider had ever told them their child had ADHD and, if so, if the child was currently taking medication for the condition.

In 2003, about 4.4 million children aged 4 to 17 (7.8 percent of US children) were reported to have been diagnosed with ADHD at some point.

Of these, 56 percent were reported to be taking medication for the disorder.

Finally, the report calculated that 4.3 percent of American children in this age range have ever been diagnosed and are taking medication.

Prevalence of Diagnosis

There were, however, considerable variations within these broad statistics. "We noted that children who had any form of healthcare coverage are more likely to be given a diagnosis of ADHD or medicated for it," Visser said. "We also noted some racial and ethnic differences in both diagnosis and treatment. Those require further attention."

In addition, boys were diagnosed with ADHD 2.5 times more frequently than girls, a number which is in line with previous reports.

The prevalence of diagnosis was higher among non-Hispanic, English-speaking, insured children, and even higher for children in families in which adults had more education.

Diagnosis was more frequent among males in families with incomes below the poverty levels vs. above the poverty level.

There were also striking regional differences for prevalence, with a low of 5 percent in Colorado to a high of 11 percent in Alabama, which may reflect different diagnostic practices.

The highest rates of medication treatment for ADHD were among males aged 12 years (9.3 percent) and females aged 11 years (3.7 percent). Non-Hispanic, English-speaking, insured children were again more likely to be receiving medication.

'Taking a Very Substantial Toll on Society'

State differences in medication treatment ranged from a low of 2.1 percent in California to a high of 6.5 percent in Arkansas.

Rates of medication treatment among those with a reported diagnosis of ADHD ranged from 40.6 percent in California to 68.5 percent in Nebraska.

"This doesn't come as an earth-shattering piece of news," said David Marks, a psychologist with the ADHD Center at Mount Sinai Medical Center in New York City. "Certainly, we know that ADHD has pretty far-reaching consequences. It does constitute a very substantial health burden."

"This speaks to the fact that this is a disorder that is really taking a very substantial toll on society," he added. "Individuals with ADHD across the developmental spectrum are at greater risk for a whole assortment of psychosocial consequences. In adulthood they miss work more, they're more likely to get fired, they're more likely to receive negative work reviews."

More information: Visit the National Institute of Mental Health for more on this condition.




Related Articles
Ty Pennington to Host ADHD Program (21 Sep 2005)
Better Sleep May Substitute for Ritalin in ADHD Kids (20 Sep 2005)
Sharp Rise in Adult Use of ADHD Drugs (15 Sep 2005)
FDA: Strattera May Prompt Suicidal Thoughts in Children (30 Sep 2005)
FDA Okays Patch as Alternative ADHD Treatment (7 Apr 2006)
Lilly to Add Suicide Warning to ADHD Drug Label (29 Sep 2005)
 
Sponsored Text Links
SkinStore.com: Strivectin SD 6oz Best Price Offer
Hydroderm: Lose wrinkles with Hydroderm
SkinStore.com: StriVectin-SD
InsureMe.com: Click here to get a free health insurance quote.
Hydroderm: Body Shape - Proven to be safe and effective - Free Trial!